Literature DB >> 8805872

HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice.

B Doe, C M Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8805872     DOI： 10.1097/00002030-199606001-00015

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

1.  Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.

Authors:  Soumi Gupta; Ramesh Janani; Qian Bin; Paul Luciw; Catherine Greer; Silvia Perri; Harold Legg; John Donnelly; Susan Barnett; Derek O'Hagan; John M Polo; Michael Vajdy
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Virus-specific cytotoxic T-lymphocyte activity elicited by coimmunization with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein.

Authors:  M J Selby; B Doe; C M Walker
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

Authors:  B Doe; M Selby; S Barnett; J Baenziger; C M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

5.  Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.

Authors:  J zur Megede; M C Chen; B Doe; M Schaefer; C E Greer; M Selby; G R Otten; S W Barnett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.

Authors:  D O'Hagan; M Singh; M Ugozzoli; C Wild; S Barnett; M Chen; M Schaefer; B Doe; G R Otten; J B Ulmer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

Authors:  Beatriz Perdiguero; Carmen Elena Gómez; Victoria Cepeda; Lucas Sánchez-Sampedro; Juan García-Arriaza; Ernesto Mejías-Pérez; Victoria Jiménez; Cristina Sánchez; Carlos Óscar S Sorzano; Juan Carlos Oliveros; Julie Delaloye; Thierry Roger; Thierry Calandra; Benedikt Asbach; Ralf Wagner; Karen V Kibler; Bertram L Jacobs; Giuseppe Pantaleo; Mariano Esteban
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

8.  Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.

Authors:  Patricia L Earl; Catherine Cotter; Bernard Moss; Thomas VanCott; Jeffrey Currier; Leigh Anne Eller; Francine McCutchan; Deborah L Birx; Nelson L Michael; Mary A Marovich; Merlin Robb; Josephine H Cox
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

9.  Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.

Authors:  J A Neidleman; M Vajdy; M Ugozzoli; G Ott; D O'Hagan
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

10.  Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

Authors:  Silvia Ratto-Kim; Jeffrey R Currier; Josephine H Cox; Jean-Louis Excler; Anais Valencia-Micolta; Doris Thelian; Vicky Lo; Eddy Sayeed; Victoria R Polonis; Patricia L Earl; Bernard Moss; Merlin L Robb; Nelson L Michael; Jerome H Kim; Mary A Marovich
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.